Target intelligence / Profile preview

Viral envelope membrane

Molecular classification
Lipid bilayer, Membrane
01

Overview

The viral envelope membrane is a lipid bilayer that surrounds the nucleocapsid of many animal viruses, typically derived from host cell membranes during the viral budding process (Wikipedia, 2024). This structure is essential for the survival and infectivity of enveloped viruses, such as HIV, influenza, and coronaviruses, as it protects the viral genome from environmental stressors (NIH, 2023). The membrane contains viral glycoproteins that mediate host cell recognition and attachment, facilitating the fusion of the viral and host membranes to release the viral contents into the cytoplasm (StatPearls, 2023). In therapeutic applications, the viral envelope is a target for various agents; for instance, docosanol is a topical antiviral that interferes with the fusion process between the host cell and the viral envelope (PubChem, 2024). Additionally, many disinfectants like ethanol and detergents act by solubilizing the lipid bilayer, thereby inactivating the virus (CDC, 2022). Because the lipid components are host-derived, targeting the membrane itself requires careful consideration of specificity to avoid damaging host cell membranes (Journal of Virology, 2021).

Other names
Viral envelopeLipid envelopeViral lipid bilayer
02

Mechanism of action

Drugs targeting the viral envelope membrane typically act by disrupting the lipid bilayer structure, leading to the loss of viral integrity and infectivity, or by inhibiting the fusion process between the viral envelope and the host cell plasma membrane (PubChem, 2024; StatPearls, 2023).

03

Biological functions

Viral entryHost cell attachmentMembrane fusionGenome protection
04

Disease associations

Infection
05

Safety considerations

Lack of specificity leading to host cell membrane damageTopical irritationLimited systemic application due to potential toxicity to host lipids
06

Interacting drugs

Docosanol

4 more in the full profile.

07

Biomarkers

Viral loadViral titer

Beyond the preview

Go deeper on Viral envelope membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral envelope membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call